Skip to content

Effects of a Supplement Containing Fucoidan on Basal Body Temperature

Effects of a Supplement Containing Fucoidan as a Major Component on Basal Body Temperature: a Placebo Controlled, Cross-over Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01399216
Enrollment
19
Registered
2011-07-21
Start date
2011-07-31
Completion date
2012-03-31
Last updated
2012-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Basal Body Temperature

Brief summary

We aim to determine whether a supplement containing fucoidan isolated from Mekabu (sporophyll of Undaria pinnatifida), EPA, and DHA has effects of elevating basal body temperature in subjects with low basal body temperature.

Interventions

DIETARY_SUPPLEMENTSupplement containing fucoidan, EPA, and DHA

75 mg fucoidan per day, for 8 weeks

DIETARY_SUPPLEMENTPlacebo

for 8 weeks

Sponsors

Three Peace Co., Ltd., Japan
CollaboratorUNKNOWN
Hiroshima University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
55 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Postmenopausal women with basal body temperature \< 36.0 ºC * Healthy as based on medical history and physical examination * Willing not to donate blood during the study * Informed consent signed

Exclusion criteria

* Renal or hepatic dysfunction * Heart disease * Participation in any clinical trial within 90 days of the commencement of the trial * Subjects who are taking medicines or functional food that may affect basal body temperature

Design outcomes

Primary

MeasureTime frame
Basal body temperatureup to 20 weeks

Secondary

MeasureTime frame
Change from baseline in serum lipid levels (total cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride)Weeks 0, 8, 12, and 20

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026